Sjuts Dustin S
Insider CIK 1796224 · RVNC President
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVNC Revance Therapeutics, Inc. | S Sale | 2024-03-18 | 2024-03-19 | 9,211 | $5.04 | $46.4K | 167,550 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2024-03-15 | 2024-03-19 | 2,967 | $5.31 | $15.8K | 176,761 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-02-29 | 2024-03-04 | 22,110 | — | $0 | 179,728 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-12-31 | 2024-01-03 | 264 | $7.47 | $2.0K | 157,618 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2023-12-15 | 2023-12-18 | 4,712 | $8.08 | $38.1K | 157,354 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-08-11 | 2023-08-15 | 22,620 | — | $0 | 170,967 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2023-08-11 | 2023-08-15 | 8,901 | $18.91 | $168.3K | 162,066 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-06-30 | 2023-07-05 | 1,000 | $15.61 | $15.6K | 148,347 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-06-09 | 2023-06-13 | 5,000 | $30.82 | $154.1K | 147,347 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-05-15 | 2023-05-16 | 21,015 | $34.55 | $726.1K | 152,347 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2023-03-15 | 2023-03-17 | 2,967 | $30.65 | $90.9K | 120,967 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-03-09 | 2023-03-09 | 21,508 | $31.59 | $679.4K | 123,934 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2023-02-15 | 2023-02-16 | 2,766 | $33.21 | $91.9K | 93,046 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 43,255 | — | $0 | 43,255 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-12-31 | 2023-01-03 | 605 | $12.18 | $7.4K | 95,812 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-12-15 | 2022-12-16 | 2,916 | $21.50 | $62.7K | 95,207 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-09-22 | 2023-03-09 | 52,396 | — | $0 | 145,442 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-06-30 | 2022-07-05 | 1,000 | $11.75 | $11.8K | 98,123 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-03-15 | 2022-03-17 | 1,835 | $15.79 | $29.0K | 97,123 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-02-15 | 2022-02-17 | 295 | $13.35 | $3.9K | 98,958 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-02-15 | 2022-02-17 | 2,134 | $13.35 | $28.5K | 99,253 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-02-02 | 2023-05-16 | 52,395 | — | $0 | 173,362 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-02-02 | 2022-02-04 | 57,016 | — | $0 | 57,016 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-12-15 | 2021-12-17 | 513 | $15.92 | $8.2K | 101,387 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-11-09 | 2021-11-10 | 35,920 | — | $0 | 101,900 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2021-06-30 | 2021-07-02 | 882 | $24.09 | $21.2K | 65,980 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-04-15 | 2021-04-16 | 411 | $28.16 | $11.6K | 65,098 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-02-15 | 2021-02-19 | 2,135 | $28.97 | $61.9K | 65,509 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-02-15 | 2021-02-19 | 275 | $28.97 | $8.0K | 67,644 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-02-02 | 2021-02-04 | 40,925 | — | $0 | 40,925 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-02-02 | 2021-02-04 | 22,620 | — | $0 | 67,919 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2020-12-31 | 2021-01-04 | 348 | $21.36 | $7.4K | 45,299 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-12-15 | 2020-12-22 | 562 | $26.75 | $15.0K | 44,951 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-09-30 | 2020-10-02 | 6,051 | $25.14 | $152.1K | 45,513 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-09-30 | 2020-10-02 | 17,500 | — | $0 | 51,564 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2020-06-30 | 2020-07-02 | 1,000 | $13.80 | $13.8K | 34,064 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-04-15 | 2020-04-17 | 432 | $14.80 | $6.4K | 33,064 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-02-15 | 2020-02-19 | 288 | $25.33 | $7.3K | 33,496 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-01-23 | 2020-01-24 | 100,000 | $22.32 | $2.23M | 100,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-01-23 | 2020-01-24 | 20,000 | — | $0 | 33,784 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2019-12-31 | 2020-01-03 | 382 | $10.82 | $4.1K | 13,784 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-12-15 | 2019-12-17 | 576 | $15.99 | $9.2K | 11,492 | SEC↗ |